The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease

@article{Hamaguchi2005TheMS,
  title={The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease},
  author={Masahide Hamaguchi and Takao Kojima and Noriyuki Takeda and Takayuki Nakagawa and Hiroya Taniguchi and Kota Fujii and Tatsushi Omatsu and Tomoaki Nakajima and Hiroshi Sarui and Makoto Shimazaki and Takahiro A. Kato and Junichi Okuda and Kazunori Ida},
  journal={Annals of Internal Medicine},
  year={2005},
  volume={143},
  pages={722-728}
}
Context The metabolic syndrome is often present in patients with nonalcoholic fatty liver disease (NAFLD), but no one knows whether it precedes NAFLD. Content At baseline, 812 members of a cohort of 4401 apparently healthy Japanese adults had NAFLD on abdominal ultrasonography. In 1 year, the authors identified 308 new cases, and NAFLD had resolved in 113 participants. Participants with the metabolic syndrome were much more likely to develop NAFLD and were less likely to experience disease… 

Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies

The combination of rising prevalence and significant potential complications warrant further research into NAFLD, particularly in areas with research gaps including Eastern Europe.

Nonalcoholic fatty liver disease: from pathogenesis to patient care

The prognosis is good for pure steatosis, whereas the presence of necrotic inflammation is associated with a significant risk of progression to cirrhosis and, possibly, hepatocellular carcinoma.

Metabolic Syndrome and Related Liver Diseases

Clinicians need to be well informed about the risk of liver disease in the patient with metabolic syndrome, given the high prevalence of overweight and obesity.

Dangerous Liaisons: The Metabolic Syndrome and Nonalcoholic Fatty Liver Disease

This issue examines the relationship between the metabolic syndrome and NAFLD in healthy Japanese men and women drinking 20 g or less of ethanol per day and confirms that Japanese persons have an elevated risk for comorbid conditions at a lower BMI than white populations.

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease

The increasing prevalence of NAFLD with advanced fibrosis, is concerning because patients appear to experience higher liver-related and non-liver-related mortality than the general population, and one that requires more in-depth analysis.

Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease occurs in individuals who do not drink excessive alcohol, yet have hepatic histology that mimics alcoholic liver disease, often associated with type 2 diabetes mellitus, central obesity, dyslipemia, and/or hypertension—conditions which comprise the metabolic syndrome.

Nonalcoholic steatohepatitis and the cardiometabolic syndrome.

Expert opinion emphasizes the importance of exercise, weight loss in obese and overweight individuals, treatment of hyperlipidemia, and glucose control for treating nonalcoholic steatohepatitis.

Metabolic Syndrome and Nonalcoholic Fatty Liver Disease

It is said that NAFLD is a risk factor for the presence of metabolic syndrome and it can be considered the hepatic expression of this syndrome.

Clinical Epidemiology of NAFLD

The increasing prevalence of NAFLD with advanced fibrosis is concerning because patients appear to experience higher liver-related and non-liver-related mortality than the general population, and one that requires more in-depth analysis.

Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population.

...

References

SHOWING 1-10 OF 37 REFERENCES

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

The presence of multiple metabolic disorders is associated with a potentially progressive, severe liver disease and the increasing prevalence of obesity, coupled with diabetes, dyslipidemia, hypertension, and ultimately the metabolic syndrome puts a very large population at risk of forthcoming liver failure in the next decades.

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.

Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics.

The aim of this work is to determine the prevalence of nonalcoholic fatty liver disease in the general population in Saudi Arabia and to describe its impact on racial groups.

The natural history of nonalcoholic fatty liver: A follow‐up study

In the absence of preexisting fibrosis or steatohepatitis, fatty liver of nonalcohol‐induced origin is an extremely benign condition.

Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

Data indicate that obesity plays a greater role than excessive alcohol intake in inducing fatty liver, and the relative roles of obesity and alcohol abuse, alone and in combination, in inducing steatosis are explored.

AGA technical review on nonalcoholic fatty liver disease.

In this review, the existing literature regarding the nomenclature, clinical and histologic spectrum, natural history, diagnosis, and management of nonalcoholic fatty liver disease are discussed.

The utility of radiological imaging in nonalcoholic fatty liver disease.

Differences between NASH and nonprogressive NAFLD were not apparent with any radiological modality, and good intraobserver agreement was evident for each modality that was superior to interob Server agreement.

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

The research agenda for the future includes establishing the role of insulin resistance and abnormal lipoprotein metabolism in NASH, determining the pathogenesis of cellular injury, defining predisposing genetic abnormalities, identifying better noninvasive predictors of disease, and defining effective therapy.

Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock?

Physicians in all disciplines need to be aware of clinical clues to the presence of NAFLD in the absence of other liver disease and in those with chronic viral hepatitis and they should be able to identify subsets at risk for liver‐related morbidity.

Fatty Infiltration of Liver in Hyperlipidemic Patients

It is indicated that ultrasonographic evidence of fatty infiltration of the liver is evident in approximately 50% of patients with hyperlipidemia, and diabetes was the only risk factor other than hypertriglyceridemia that was significantly associated with fatty infiltration.